Statements of Operations (USD $)	12 Months Ended					98 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011	Dec. 31, 2013
Revenues
Products	$ 1,117,524	[1]	$ 578,352	[1]	$ 538,005	$ 3,045,787
Government contracts	198,953		618,811		3,411,906	9,866,002
Total Revenues	1,316,477		1,197,163		3,949,911	12,911,789
Costs and Expenses
Research, development and manufacturing operations	21,342,519		20,728,553		24,121,766	121,756,756
Selling, general and administrative	7,390,884		5,008,388		7,130,530	48,221,301
Impairment loss	822,350		3,401,610		78,000,000	83,993,440
Total Costs and Expenses	29,555,753		29,138,551		109,252,296	253,971,497
Loss from Operations	(28,239,276)		(27,941,388)		(105,302,385)	(241,059,708)
Other Income/(Expense)
Other Income/(Expense), net	(576,292)		(828,029)		(440,230)	468,806
Change in fair value of make-whole dividend liability	(1,315,383)		0		0	(1,315,383)
Total Other Income/(Expense)	(1,891,675)		(828,029)		(440,230)	(846,577)
Net Loss	(30,130,951)		(28,769,417)		(105,742,615)	(241,906,285)
Deemed dividends on preferred stock and accretion of warrants	(5,935,762)		0		0.00	(5,935,762)
Net Loss applicable to common stockholders	$ (36,066,713)		$ (28,769,417)		$ (105,742,615)	$ (247,842,047)
Net Loss Per Share (Basic and diluted) (in dollars per share)	$ (0.66)		$ (0.66)		$ (3.02)
Weighted Average Common Shares Outstanding (Basic and diluted) (in shares)	54,556,877		43,850,322		34,985,914

[1] Includes related party revenue of $142,500 and $404,680 for the years ended December 31, 2013 and 2012, respectively. See Note 13.